Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.
about
Peritoneal mesothelioma: a reviewChinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignanciesHyperthermia: How Can It Be Used?Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review-past, present and futureRepeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomesPalliative cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: current clinical practice or misnomer?Diagnosis and management of patients with malignant peritoneal mesotheliomaChemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapyLooking up: Recent advances in understanding and treating peritoneal carcinomatosisHyperthermia using nanoparticles--Promises and pitfalls.Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report.Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery.Management of pseudomyxoma peritonei.Malignant peritoneal mesothelioma: a reviewMalignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysisProspective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases.Malignant pleural and peritoneal mesothelioma consequential to brief indirect asbestos exposure.Advances in the management of peritoneal mesotheliomaClinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma.Malignant peritoneal mesothelioma.Early and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Experience with peritoneal mesothelioma at the Milan National Cancer Institute.Peritoneal mesothelioma in a woman who has survived for seven years: a case report.Perioperative intraperitoneal chemotherapy for peritoneal surface malignancyMalignant peritoneal mesothelioma presenting with persistent high fever.Changing pattern in malignant mesothelioma survivalEffects of sex hormones on survival of peritoneal mesothelioma.A Comparison of Intravenous plus Intraperitoneal Chemotherapy with Intravenous Chemotherapy Alone for the Treatment of Gastric Cancer: A Meta-Analysis.Distinctive clinical characteristics of malignant mesothelioma in young patients.High-quality results of cytoreductive surgery and heated intraperitoneal chemotherapy perfusion for carcinomatosis at a low volume institution.Two 27 MHz Simple Inductive Loops, as Hyperthermia Treatment Applicators: Theoretical Analysis and Development.Malignant peritoneal mesothelioma in a patient with intestinal fistula, incisional hernia and abdominal infection: A case report.A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma.Malignant pleural mesothelioma in a 17-year old boy: A case report and literature review.The emerging role of molecular imaging and targeted therapeutics in peritoneal carcinomatosis.Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy.Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesotheliomaCytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: hemodynamic, metabolic, and anesthetic considerationsPeritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapyComplete peritonectomy and intraperitoneal chemotherapy for recurrent rectal cancer with peritoneal metastasis
P2860
Q24680847-9DEC13E0-4556-4A11-96BF-357C5F478F26Q26738517-1B622885-296D-46EF-BAA2-7FD861CD891EQ26750635-C6E20FC1-9276-4A96-8433-722461A402DAQ26768296-CAE16229-9081-4995-A718-03B55BDF4C8AQ26768299-B9C57AD3-C175-4CB7-81F5-947767811F4BQ26768306-FF7D605D-4F1F-45B6-9BF5-16316C42287DQ26768364-C1473285-5905-404D-AABF-8359825D7319Q26768402-855DAA70-8E1C-412F-9D9F-B224570884EEQ26849259-526266BA-919A-4A3A-B1AB-DC309AFE9673Q28384618-288630F6-7303-4102-BF64-391DB775B960Q33266936-D6E28FF0-9122-4A42-BF5E-3985CB98E610Q33398380-FDBE033B-78B6-42CE-97C0-211003475729Q33868978-61C6030C-619B-462F-807E-E5A7A6CC7E62Q33871582-10B8CF63-BBE7-4222-9526-C72708E80693Q33909330-E649647F-DA8C-42D2-AD8B-7698DD199F94Q33931049-24D4BD05-3942-40AD-A103-D36524C84BC0Q34080881-B54F42AA-7BBC-41DC-AE7A-19BF6A7255FFQ34137322-83C74BEE-3EB4-405D-99C3-84F066B1FDC1Q34267563-65B771F2-EE6C-4530-87D7-E1CFFE2C4204Q34390899-E456C920-CFAA-4501-AFD2-62F7448EC1ACQ34391061-B0350821-8469-48A1-A192-7CCC783C79D6Q34391082-56FDF771-2F47-401D-B470-7D7ABD52B7DCQ34589641-03088DB6-CD3A-446A-9938-5F92DB48CA1EQ34690528-C450DE29-97C4-4C2D-85D9-EEA5F9177EE2Q34919238-52EEDD1C-F190-4E7C-93A8-8A7CD0190566Q35150628-54E48890-C89D-4CBB-9D6D-D65CF1BB2C63Q35816736-E1E6C88F-4DAE-4517-80B7-C9D15A2B5690Q35898235-8AB8C92C-C76C-4258-A865-A8013191D9A4Q36140968-7185A86A-2147-4D90-BF15-5BDC7C9FCC55Q36306819-CAE55BF3-7C80-434F-8156-D5266A1F3491Q36328873-D319B3B6-F13B-4B49-80A7-9A814502C5A6Q36640710-31AE1812-11A5-4935-A08E-1288D943388BQ36665886-E6D61FB0-5199-4801-897C-A8AD444456DAQ36766690-4667C763-B59D-468D-9739-5F8A0A9FDAC5Q36903804-5CB9ACD0-CD5F-4B23-89C6-DDF0ECC8F910Q36911440-28F9C01A-93BA-4D65-A241-91E03F4F3CDDQ37074080-0D30D39A-FC73-4F05-99EF-432376A3193DQ37087589-2946233A-DAF9-4613-9DB2-8324DF6EFCDFQ37090867-F37903C8-C290-45C7-9E68-3832413607ABQ37122615-E0410A06-0156-4C5C-ADEE-34FF57CA2121
P2860
Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Analysis of factors associated ...... intraperitoneal chemotherapy.
@ast
Analysis of factors associated ...... intraperitoneal chemotherapy.
@en
Analysis of factors associated ...... intraperitoneal chemotherapy.
@nl
type
label
Analysis of factors associated ...... intraperitoneal chemotherapy.
@ast
Analysis of factors associated ...... intraperitoneal chemotherapy.
@en
Analysis of factors associated ...... intraperitoneal chemotherapy.
@nl
prefLabel
Analysis of factors associated ...... intraperitoneal chemotherapy.
@ast
Analysis of factors associated ...... intraperitoneal chemotherapy.
@en
Analysis of factors associated ...... intraperitoneal chemotherapy.
@nl
P2093
P356
P1476
Analysis of factors associated ...... d intraperitoneal chemotherapy
@en
P2093
David J Liewehr
David L Bartlett
H Richard Alexander
James F Pingpank
Seth M Steinberg
Sharon M Mavroukakis
Steven K Libutti
Tatiana H Beresnev
P304
P356
10.1200/JCO.2003.04.150
P407
P577
2003-12-01T00:00:00Z